The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Toxicity of 5-aza-2'-deoxycytidine to mammalian cells is mediated primarily by covalent trapping of DNA methyltransferase rather than DNA demethylation.
Open accessAbstract
The deoxycytidine analog 5-aza-2'-deoxycytidine (5-azadCyd) has been widely used as a DNA methylation inhibitor to experimentally induce gene expression and cellular differentiation. Prior to the availability of mutant mice with altered DNA methyltransferase levels, treatment of cells with drugs has been the only means to experimentally manipulate the level of genomic DNA methylation in mammalian cells. Substitution of DNA with 5-azadCyd leads to covalent trapping of the enzyme, thereby depleting the cells of enzyme activity and resulting in DNA demethylation. 5-AzadCyd or 5-azacytidine treatment causes multiple changes in treated cells, including activation of silent genes, decondensation of chromatin, and induction of cellular differentiation, all of which are believed to be consequences of drug-induced demethylation. 5-AzadCyd is highly toxic in cultured cells and animals and is utilized as a potent antitumor agent for treatment of certain human cancers. It has been postulated that the toxicity of the drug in mammalian cells is also due to its inhibition of DNA methylation. The chemistry of the methylation reaction is consistent, however, with an alternative mechanism: the cytotoxic effect of 5-azadCyd may be directly mediated through the covalent binding of DNA methyltransferase to 5-azadCyd-substituted DNA. We have tested this possibility by using embryonic stem cells and mice with reduced levels of DNA methyltransferase due to a targeted mutation of the gene. When exposed to 5-azadCyd mutant embryonic stem cells or embryos were significantly more resistant to the toxic effects of the drug than wild-type cells and embryos, respectively. These results strongly suggest that the cellular DNA methyltransferase itself, rather than the secondary demethylation of genomic DNA, is the primary mediator of 5-azadCyd cytotoxicity. In light of our results, some conclusions from previous studies using 5-azadCyd in order to experimentally manipulate cellular methylation levels may have to be reassessed. Also, our data make clear predictions for cancer treatment: tumor cells with elevated DNA methyltransferase levels would be expected to be susceptible to treatment with 5-azadCyd, whereas tumors with reduced levels of the enzyme would be resistant.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Church, G. M., & Gilbert, W. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.7.1991 · Cited by 8,116
Targeted mutation of the DNA methyltransferase gene results in embryonic lethality
Li, E., Bestor, T. H., & Jaenisch, R. (1992) · Cell · doi:10.1016/0092-8674(92)90611-f · Cited by 3,984
Self-citationHypomethylation distinguishes genes of some human cancers from their normal counterparts
Feinberg, A. P., & Vogelstein, B. (1983) · Nature · doi:10.1038/301089a0 · Cited by 2,437
Role for DNA methylation in genomic imprinting
Li, E., Beard, C., & Jaenisch, R. (1993) · Nature · doi:10.1038/366362a0 · Cited by 1,964
Self-citationRole for DNA methylation in genomic imprinting
Li, E., Beard, C., & Jaenisch, R. (1994) · Trends in Genetics · doi:10.1016/0168-9525(94)90228-3 · Cited by 1,691
Self-citationSimplified mammalian DNA isolation procedure
Laird, P. W., Zijderveld, A., Linders, K., Rudnicki, M. A., Jaenisch, R., & Berns, A. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.15.4293 · Cited by 1,494
Self-citationHhal methyltransferase flips its target base out of the DNA helix
Klimasauskas, S., Kumar, S., Roberts, R. J., & Cheng, X. (1994) · Cell · doi:10.1016/0092-8674(94)90342-5 · Cited by 945
The 5-methylcytosine content of DNA from human tumors
Gama-Sosa, M. A., Slagel, V. A., Trewyn, R. W., Oxenhandler, R., Kuo, K. C., Gehrke, C. W., & Ehrlich, M. (1983) · Nucleic Acids Research · doi:10.1093/nar/11.19.6883 · Cited by 844
Arabidopsis thaliana DNA Methylation Mutants
Vongs, A., Kakutani, T., Martienssen, R. A., & Richards, E. J. (1993) · Science · doi:10.1126/science.8316832 · Cited by 706
Creusot, F., Acs, G., & Christman, J. K. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)68144-5 · Cited by 564
Covalent bond formation between a DNA-cytosine methyltransferase and DNA containing 5-azacytosine.
Santi, D. V., Norment, A., & Garrett, C. E. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.22.6993 · Cited by 518
Reduced genomic 5-methylcytosine content in human colonic neoplasia.
Feinberg, A. P., Gehrke, C. W., Kuo, K. C., & Ehrlich, M. (1988) · PubMed · Cited by 484
Kinetic and catalytic mechanism of HhaI methyltransferase.
Wu, J. C., & Santi, D. V. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)61263-3 · Cited by 420
Laird, P., & Jaenisch, R. (1994) · Human Molecular Genetics · doi:10.1093/hmg/3.suppl_1.1487 · Cited by 408
Self-citationAltering gene expression with 5-azacytidine
Jones, P. A. (1985) · Cell · doi:10.1016/0092-8674(85)90192-8 · Cited by 397
Increased Cytosine DNA-Methyltransferase Activity During Colon Cancer Progression
Issa, J.-P. J., Vertino, P. M., Wu, J., Sazawal, S., Celano, P., Nelkin, B. D., Hamilton, S. R., & Baylin, S. B. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.15.1235 · Cited by 312
Wu, J., Issa, J. P., Herman, J., Bassett, D. E., Nelkin, B. D., & Baylin, S. B. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.19.8891 · Cited by 253
Direct identification of the active-site nucleophile in a DNA (cytosine-5)-methyltransferase
Chen, L., MacMillan, A. M., Chang, W., Ezaz-Nikpay, K., Lane, W. S., & Verdine, G. L. (1991) · Biochemistry · doi:10.1021/bi00110a002 · Cited by 249
Parental imprinting of autosomal mammalian genes
Efstratiadis, A. (1994) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(05)80054-1 · Cited by 201
Distinct hypermethylation patterns occur at altered chromosome loci in human lung and colon cancer.
Makos, M., Nelkin, B. D., Lerman, M. I., Latif, F., Zbar, B., & Baylin, S. B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.5.1929 · Cited by 163
Cell cycle-specific reactivation of an inactive X-chromosome locus by 5-azadeoxycytidine.
Jones, P. A., Taylor, S. M., Mohandas, T. K., & Shapiro, L. J. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.4.1215 · Cited by 143
Jaenisch, R., Schnieke, A., & Harbers, K. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.5.1451 · Cited by 142
Self-citationPinto, A., & Zagonel, V. (1993) · PubMed · Cited by 133
Abnormal Chromosome Behavior in Neurospora Mutants Defective in DNA Methylation
Foss, H. M., Roberts, C. J., Claeys, K. M., & Selker, E. U. (1993) · Science · doi:10.1126/science.7505062 · Cited by 128
Abele, R., Clavel, M., Dodion, P. F., Bruntsch, U., Gundersen, S., Smyth, J., Renard, J., Glabbeke, M. M. V., & Pinedo, H. M. (1987) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(87)90060-5 · Cited by 120
Phase I and pharmacokinetic study of 5-aza-2'-deoxycytidine (NSC 127716) in cancer patients.
van Groeningen, C. J., LEYVA, A., O'Brien, A. M. P., Gall, H. E., & Pinedo, H. M. (1986) · PubMed · Cited by 119
Wilson, V. L., Jones, P. A., & Momparler, R. L. (1983) · PubMed · Cited by 118
DNA Methylation in 5-Aza-2′-Deoxycytidine-Resistant Variants of C3H 10T1/2 C18 Cells
FLATAU, E., Gonzales, F. A., Michalowsky, L. A., & Jones, P. A. (1984) · Molecular and Cellular Biology · doi:10.1128/mcb.4.10.2098 · Cited by 80
Michalowsky, L. A., & Jones, P. A. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.9.3076-3083.1987 · Cited by 78
Jablonka, E., Goitein, R., Marcus, M., & Cedar, H. (1985) · Chromosoma · doi:10.1007/bf00293162 · Cited by 76
Momparler, R. L., Bouchard, J., & Samson, J. (1985) · Leukemia Research · doi:10.1016/0145-2126(85)90123-7 · Cited by 72
Activation of an imprinted Igf 2 gene in mouse somatic cell cultures.
Eversole-Cire, P., Ferguson‐Smith, A. C., Sasaki, H., Brown, K. D., Cattanach, B. M., Gonzales, F. A., Surani, M. A., & Jones, P. A. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.8.4928 · Cited by 58
DNA modification, differentiation, and transformation
Jones, P. A., Taylor, S. M., & Wilson, V. L. (1983) · Journal of Experimental Zoology · doi:10.1002/jez.1402280212 · Cited by 42
Cytotoxicity of 5-Aza-2′-deoxycytidine in a mammalian cell system
Davidson, S. M., Crowther, P. J., Radley, J., & Woodcock, D. M. (1992) · European Journal of Cancer · doi:10.1016/s0959-8049(05)80054-1 · Cited by 35
5-Azadeoxycytidine induced undercondensation in the giant X chromosomes of Microtus agrestis
Haaf, T., & Schmid, M. (1989) · Chromosoma · doi:10.1007/bf00291043 · Cited by 24
Richel, D. J., Colly, L. P., Lurvink, E. G. A., & Willemze, R. (1988) · British Journal of Cancer · doi:10.1038/bjc.1988.298 · Cited by 24
Cited by
DNA methylation patterns and epigenetic memory
Bird, A. (2002) · Genes & Development · doi:10.1101/gad.947102 · Cited by 7,124
Jaenisch, R., & Bird, A. (2003) · Nature Genetics · doi:10.1038/ng1089 · Cited by 6,325
Self-citationDNA methylation and its basic function
Moore, L. D., Le, T., & Fan, G. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2012.112 · Cited by 4,906
Epigenetics in human disease and prospects for epigenetic therapy
Egger, G., Liang, G., Aparicio, A., & Jones, P. A. (2004) · Nature · doi:10.1038/nature02625 · Cited by 3,232
The history of cancer epigenetics
Feinberg, A. P., & Tycko, B. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1279 · Cited by 2,344
Metadata
- Authors
- Jüttermann, R., Li, E., & Jaenisch, R.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1994-12-06
- Volume
- 91
- Issue
- 25
- Pages
- 11797-11801
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2024088186
- Cited by
- 678
- References
- 36
- FWCI
- 2.82
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.